» Articles » PMID: 31108916

Role of Transforming Growth Factor-β in Skeletal Muscle Fibrosis: A Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 May 22
PMID 31108916
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Transforming growth factor-beta (TGF-β) isoforms are cytokines involved in a variety of cellular processes, including myofiber repair and regulation of connective tissue formation. Activation of the TGF-β pathway contributes to pathologic fibrosis in most organs. Here, we have focused on examining the evidence demonstrating the involvement of TGF-β in the fibrosis of skeletal muscle particularly. The TGF-β pathway plays a role in different skeletal muscle myopathies, and TGF-β signaling is highly induced in these diseases. In this review, we discuss different molecular mechanisms of TGF-β-mediated skeletal muscle fibrosis and highlight different TGF-β-targeted treatments that target these relevant pathways.

Citing Articles

Vitamin D and its receptor in skeletal muscle are associated with muscle disease manifestation, lipid metabolism and physical fitness of patients with myositis.

Vernerova L, Vokurkova M, Laiferova N, Nemec M, Spiritovic M, Mytiai O Arthritis Res Ther. 2025; 27(1):48.

PMID: 40038731 PMC: 11877867. DOI: 10.1186/s13075-025-03516-9.


Effects and mechanisms of APP and its cleavage product Aβ in the comorbidity of sarcopenia and Alzheimer's disease.

Wu J, Tang J, Huang D, Wang Y, Zhou E, Ru Q Front Aging Neurosci. 2024; 16:1482947.

PMID: 39654807 PMC: 11625754. DOI: 10.3389/fnagi.2024.1482947.


Endothelial-mesenchymal transition in skeletal muscle: Opportunities and challenges from 3D microphysiological systems.

Francescato R, Moretti M, Bersini S Bioeng Transl Med. 2024; 9(5):e10644.

PMID: 39553431 PMC: 11561840. DOI: 10.1002/btm2.10644.


Exploring novel natural compound-based therapies for Duchenne muscular dystrophy management: insights from network pharmacology, QSAR modeling, molecular dynamics, and free energy calculations.

Saeed M, Haque A, Shoaib A, Danish Rizvi S Front Pharmacol. 2024; 15:1395014.

PMID: 39415830 PMC: 11481126. DOI: 10.3389/fphar.2024.1395014.


Fibrosis and Sports Injuries: Concept and Implications: The GESMUTE-SETRADE Consensus Statement.

Beas-Jimenez J, Leon Garrigosa A, Donoro Cuevas P, Alvarez Recio M, Cofre Bolados C, Alonso J Orthop J Sports Med. 2024; 12(9):23259671241266604.

PMID: 39291125 PMC: 11406605. DOI: 10.1177/23259671241266604.


References
1.
Branton M, Kopp J . TGF-beta and fibrosis. Microbes Infect. 1999; 1(15):1349-65. DOI: 10.1016/s1286-4579(99)00250-6. View

2.
Abrams R, Tsai A, Watson B, Jamali A, Lieber R . Skeletal muscle recovery after tenotomy and 7-day delayed muscle length restoration. Muscle Nerve. 2000; 23(5):707-14. DOI: 10.1002/(sici)1097-4598(200005)23:5<707::aid-mus7>3.0.co;2-t. View

3.
Lalani R, Bhasin S, Byhower F, Tarnuzzer R, Grant M, Shen R . Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. J Endocrinol. 2000; 167(3):417-28. DOI: 10.1677/joe.0.1670417. View

4.
Ishitobi M, Haginoya K, Zhao Y, Ohnuma A, MINATO J, Yanagisawa T . Elevated plasma levels of transforming growth factor beta1 in patients with muscular dystrophy. Neuroreport. 2001; 11(18):4033-5. DOI: 10.1097/00001756-200012180-00026. View

5.
Ilzecka J, Stelmasiak Z, Dobosz B . Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis. Cytokine. 2003; 20(5):239-43. DOI: 10.1006/cyto.2002.2005. View